Overview
NXTS market data
Price History
NXTS price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for NXTS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Nexentis Technologies Files Prospectus For Offering 2.573M Common Shares On Behalf Of Selling ShareholdersBenzinga · Jul 13, 2026, 8:12 PM
Nexentis Technologies Subsidiary Completes Analysis Of SLC Transport Proteins, Starts Global AI Drug Discovery Initiative With BoltzBenzinga · Jul 7, 2026, 12:35 PM
Nexentis Technologies Amends Its Loan And Partnership Agreement With Solterra Renewable Energy, Other Lenders For Melz Solar Project; Solterra To Make Early Partial Repayments Of ~$147K On Its Part Of Loan, $98K For Sale Of 10% Of Its Profit Rights;Benzinga · Jun 29, 2026, 12:30 PM
Crude Oil Down Over 1%; US Manufacturing PMI Surges In JuneBenzinga · Jun 23, 2026, 4:05 PM
Nexentis Technologies Files Prospectus For Offering 410,998 Common Shares At $7.056/ShareBenzinga · Jun 23, 2026, 2:15 PM
Dow Falls Over 300 Points; Korn Ferry Earnings Top ViewsBenzinga · Jun 23, 2026, 1:55 PM
8-K filing — Nexentis Technologies Inc. (NXTS)SEC EDGAR · Jun 22, 2026, 8:49 PM
Crude Oil Falls Over 2%; Getty Images Shares Spike HigherBenzinga · Jun 22, 2026, 4:10 PM
Dow Jumps 200 Points; Outdoor Holding Shares Fall After Q4 ResultsBenzinga · Jun 22, 2026, 1:55 PM
Nexentis Technologies Subsidiary MitoCareX Bio Partners With AI Biomolecular Drug Discovery Research Lab Boltz To Accelerate Identification Of Novel Small-Molecule Scaffolds Targeting Selected Solute Carrier ProteinsBenzinga · Jun 22, 2026, 12:30 PM